Navigation Links
Cellceutix CEO, Leo Ehrlich, Conducts Interview with "Biotech Stock Trader"; Dr. Paul Ginsberg, (Renowned Patent Attorney) Joins Cellceutix Advisory Board
Date:4/18/2011

>

Commenting on joining the Cellceutix Advisory Board, Dr. Ginsburg stated, "I have been working closely with Cellceutix and Dr. Menon for some time now and based on my past experience in the field, I see great potential in the Company.  I am both pleased and excited to join the exceptional Cellceutix team and look forward to what the future may hold with not only Kevetrin™, but KM-391 for autism and other drugs in the pipeline which I have gotten to know quite well."

About Dr. Ginsberg

Dr. Ginsburg received his Ph.D. in Chemistry from the City University of New York and his law degree from Columbia University where he was a Harlan Fiske Stone Scholar.  He was elected to Phi Beta Kappa at the City College of New York and to the scientific research honor society Sigma Xi at CUNY. 

Dr. Ginsburg has spent most of his career as corporate counsel representing large and small pharmaceutical, biotechnology, chemical and consumer products companies.  His last position was at Pfizer Inc., where he served as Head of the New York Patent Department which dealt with several blockbuster products, including Viagra and Chantix.  He represented Pfizer on the intellectual property committees of the National Association of Manufacturers, the Chemical Manufacturers Association and the Biotechnology Industry Organization. Dr. Ginsburg has lectured widely on pharmaceutical and biotechnology patent prosecution and licensing at the Practicing Law Institute and Columbia Law School . Prior to his twenty year career at Pfizer, Dr. Ginsburg was a senior attorney at Schering-Plough. He was subsequently recruited by Merck and then by the highly respected IP law firm, Fish & Neave.

Dr. Ginsburg is perhaps most well-known as the author of the patent covering Schering-Plough's hugely successful product Claritin. He also authored important patents covering Schering-Plough's highly successful alpha-interferon product.

D
'/>"/>

SOURCE Cellceutix Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cellceutix Poster Presentation on its p53 Cancer Breakthrough Attracts Wide Interest at 102nd AACR Meeting
2. Cellceutix Reports Production of Its Anti-Cancer Drug Kevetrin™ Has Begun
3. Cellceutix Reports Confidential Disclosure Agreement Signed With Major Pharmaceutical Company
4. Cellceutix Discovers Drug Activates Guardian Angel p53 in Fight Against Leukemia
5. Cellceutix Cancer Drug Kevetrin™ Shows No Genotoxicity in Study
6. Sonic Innovations Conducts National Training Events for Government Clinicians
7. Impliant Conducts the First Two Implantations of Its New TOPS VersaLink Spinal System
8. Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
9. Maine Natural Health Company Conducts Dental Clinical Trial
10. OXIS International Executives Interviewed on StockGoodies.com Radio
11. Cardiogenesis Executive Chairman Paul J. McCormick Updates Commercial and Regulatory Progress in Interview With Wall Street Reporter, Available Online
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... 2015 UHC has released the findings of ... devices based on cost and quality outcomes to uncover ... The study examined utilization of PPIs—which can account for ... —at 10 academic medical centers, focusing on procedures utilizing ... The study, begun in 2013, integrated ...
(Date:3/31/2015)... March 31, 2015 Uroplasty, Inc. (NASDAQ:  UPI) ... completion of their merger. The merger was originally ... all-stock combination creates a new medical device company ... 2015, Cogentix Medical, Inc. will trade on the ... have its U.S. headquarters in Minnetonka, ...
(Date:3/31/2015)... March 31, 2015 /CNW/ - Today, the Honourable Rona Ambrose, ... animal health organizations to discuss the Government of ... (AMR). The roundtable provided an important ... share their priorities and discuss roles and responsibilities in ... their optimal use (also known as antimicrobial stewardship) was ...
Breaking Medicine Technology:UHC Study: Variations in Use of Physician Preference Items Affect Patient Outcomes and Costs 2UHC Study: Variations in Use of Physician Preference Items Affect Patient Outcomes and Costs 3Uroplasty and Vision-Sciences Complete Merger 2Uroplasty and Vision-Sciences Complete Merger 3Uroplasty and Vision-Sciences Complete Merger 4Government of Canada hosts roundtable discussion to advance Canada's work on antimicrobial resistance 2Government of Canada hosts roundtable discussion to advance Canada's work on antimicrobial resistance 3Government of Canada hosts roundtable discussion to advance Canada's work on antimicrobial resistance 4
... BRIDGEWATER, N.J., May 03, 2007 /PRNewswire-FirstCall/ ... specialty pharmaceutical company,through its Pharmaceuticals Division, ... pharmacokinetic study of its investigational,abuse-deterrent, extended-release ... of the American Pain Society in ...
... 02, 2007 /PRNewswire-FirstCall/ --,Genelabs Technologies, Inc. announced ... the 20th International Conference on Antiviral,Research being ... hepatitis C virus (HCV) polymerase inhibitor,discovered by ... by Christopher D. Roberts,Ph.D., Director of Medicinal ...
Cached Medicine Technology:Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 2Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 3Alpharma Presents Positive Pharmacokinetic Study Results of Its,Investigational Abuse-Deterrent, Extended-Release Opioid 4Genelabs Technologies Announces Presentation of Data on,Non-Nucleoside HCV Polymerase Inhibitor at 20th International,Conference on Antiviral Research Meeting 2Genelabs Technologies Announces Presentation of Data on,Non-Nucleoside HCV Polymerase Inhibitor at 20th International,Conference on Antiviral Research Meeting 3
(Date:3/31/2015)... New York, New York (PRWEB) March 31, 2015 ... on behalf of individuals who allegedly developed new-onset Type ... medication continue to move forward in the federal multidistrict ... South Carolina. According to an Order issued on March ... will begin on November 4, 2015. (In re Lipitor ...
(Date:3/31/2015)... DataEntryOutsourced is pleased to announce the availability of ... the specialized requirements imposed by food production and nutritional ... for a wide array of products. DEO is currently ... entry services. , DataEntryOutsourced recently published a special ... Scale Data Entry." This case study highlighted the challenges ...
(Date:3/31/2015)... 31, 2015 Indiana Fiber Network, ... Provider, announces that Joink, LLC selected IFN as ... According to Cory Childs, IFN Enterprise Sales Manager, ... targeted at Internet Service Providers, Telecom companies, and ... provides Joink with diverse protected transport from their ...
(Date:3/31/2015)... 2015 CirugiaPlastica-Mexico.net , an ... the VisitandCare.com company, announced today an expansion of ... Embracing the most experienced and committed plastic surgeons ... to obtain elegant, life-altering cosmetic enhancements. Overall, a ... surgery clinics in Mexico due to the improved ...
(Date:3/31/2015)... For its fourth consecutive year, Survivor Spin, an award winning ... is hoping to raise thousands of dollars at its upcoming ... Fitness (LCF) in Maywood, IL. , Twenty-Seven ... Nicole Capone, launched the Survivor Spin Relay in 2012, a ... fun-filled evening of friendly indoor cycling competition accompanied with live ...
Breaking Medicine News(10 mins):Health News:Lipitor Lawsuit News: Jury Selection for First Federal Bellwether Trial to Commence November 4th 2Health News:Lipitor Lawsuit News: Jury Selection for First Federal Bellwether Trial to Commence November 4th 3Health News:DEO Announces a Team of Dedicated Data Entry Operators for Nutrition Score Data Entry 2Health News:Indiana Fiber Network, LLC was selected by Joink, LLC as Middle Mile Fiber Transport Provider 2Health News:Indiana Fiber Network, LLC was selected by Joink, LLC as Middle Mile Fiber Transport Provider 3Health News:CirugiaPlastica-Mexico.net Offering More Expertise in Plastic Surgery with the Addition of New Providers 2Health News:CirugiaPlastica-Mexico.net Offering More Expertise in Plastic Surgery with the Addition of New Providers 3Health News:CirugiaPlastica-Mexico.net Offering More Expertise in Plastic Surgery with the Addition of New Providers 4Health News:Upcoming Survivor Spin Relay Fundraiser Hopes to Raise Thousands of Dollars for Cancer Patients 2Health News:Upcoming Survivor Spin Relay Fundraiser Hopes to Raise Thousands of Dollars for Cancer Patients 3
... respond to early trauma seems to play a role, ... Post-traumatic stress disorder (PTSD) increases the risk of suicide ... participants who were tracked for 15 years after they ... Interviews were conducted with the participants when they were ...
... Pa., March 2 As Pennsylvania Game Commission wildlife ... sites where bats have been confirmed infected or dying ... The sites are two abandoned mines near Carbondale, Lackawanna ... the abandoned Shindle Iron Mine, Aitkin Cave and Seawra ...
... Inc. (Nasdaq: OREX ) today announced that ... of Directors to fill an existing vacancy on the ... executive management experience. He was the founder of ... from its inception through its acquisition eight years later. ...
... 2 The AAWC Wound Care Specialty Council,s ... content validation results for its "Guideline of Pressure ... Panel,s (NPUAP) 11th Biennial Conference, February 27-28, 2009, ... patients, caregivers and healthcare systems. According to the ...
... March 2, 2009) Two new studies in ... aimed at preventing shaken baby syndrome increased knowledge of ... one trigger for people abusing babies by shaking them. ... shaken baby syndrome and advise them on strategies for ...
... economic climate, raising money for charity isn,t the easiest task. ... are challenged to address their own essential needs. But according ... no better way to spend your day than supporting an ... sting from the current economy, and it can be depressing," ...
Cached Medicine News:Health News:Post-Traumatic Stress Tied to Increased Suicide Risk 2Health News:WNS Identified at Six Sites in Pennsylvania 2Health News:Orexigen(R) Therapeutics Names Patrick Mahaffy to Board of Directors 2Health News:Association for the Advancement of Wound Care (AAWC) Leads Pressure Ulcer Care Initiative 2Health News:Educational materials increase knowledge and behaviors important for preventing shaken baby syndrome 2Health News:Educational materials increase knowledge and behaviors important for preventing shaken baby syndrome 3Health News:SCAN Health Plan Arizona Supports Fight Against Parkinson's 2
... Horizon Phacoemulsification System is a ... Lightweight and portable, it offers ... a small console. It also ... perform anterior segment surgery. These ...
... Isoseeds I-125 are brachytherapy sources which are ... localized tumors, especially in the prostate. The ... conclusion of the therapeutic effect, i.e. after ... intended for single use. They are supplied ...
Mirror prismatic gonioscope. Titanium body....
Four 62 mirrors give a 360 view of the anterior chamber angle with only a slight lens rotation. Posterior pole can be viewed through center of lens....
Medicine Products: